argenx SE: updates and filings

ARGXNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$942.04

November 19, 2026Market cap $58.3B

What Ploutos Investor adds for argenx

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from 2015
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 19, 2026 latest annual
  • Nov 9, 2026Current report (foreign company)
    Form6-K
  • Nov 9, 2026Current report (foreign company)
    Form6-K
  • Nov 5, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 22, 2026Current report (foreign company)
    Form6-K
  • Oct 19, 2026Current report (foreign company)
    Form6-K
  • Oct 8, 2026Current report (foreign company)
    Form6-K
  • Sep 29, 2026Current report (foreign company)
    Form6-K
  • Aug 27, 2026Current report (foreign company)
    Form6-K
  • Aug 27, 2026Filing (amendment)
    FormSC TO-T/A
  • Aug 19, 2026Filing (amendment)
    FormSC TO-T/A
  • Aug 17, 2026Current report (foreign company)
    Form6-K
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 6, 2026Filing (amendment)
    FormSC TO-T/A
  • Aug 6, 2026Filing
    FormSC TO-T
  • Aug 3, 2026Current report (foreign company)
    Form6-K
  • Jul 28, 2026Filing
    FormSC TO-C
  • Jul 27, 2026Filing
    FormSC TO-C
  • Jul 27, 2026Current report (foreign company)
    Form6-K
  • Jul 23, 2026Current report (foreign company)
    Form6-K
  • Jun 23, 2026Current report (foreign company)
    Form6-K
  • Jun 3, 2026Current report (foreign company)
    Form6-K
  • May 11, 2026Current report (foreign company)
    Form6-K
  • May 7, 2026Current report (foreign company)
    Form6-K
  • May 6, 2026Current report (foreign company)
    Form6-K
  • May 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Mar 1, 2017.

The full analysis

What do argenx's filings show?

The filings are where every one of argenx's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.